TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Wednesday, September 24, 2008

Ups and Downs for Drug Stocks

The WSJ Health Blog reports on how more transparency at the FDA could cause volatility in drug stocks.   Under a law passed last year, the FDA is just beginning to post quarterly lists of drugs "that could, possibly, carry previously unreported side effects."    The Health Blog notes the lists are just preliminary, but could cause market swings.


Legislation, Reforms, & Political News | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Ups and Downs for Drug Stocks:


Post a comment